First Phase 3 Clinical Trials Targeting The Tauopathy Of Alzheimers Disease - Claude Wischik

First Phase 3 Clinical Trials Targeting the Tauopathy of Alzheimer’s Disease - Claude Wischik

SENS Research Foundation

Clinical Trials, FAD Variants, and the Etiology of Alzheimer’s Disease

Icahn School of Medicine

TauRx Dementia study at ReCognition Health

Re:Cognition Health

Targeting Tau in Alzheimer's Disease

TauRxTherapeutics

NHK Report on Taurx

Prof Claude Wischik

The Future of Tau Focused Therapies

TauRxTherapeutics

Dr. Jeffrey Cummings - Alzheimer's Clinical Trials: History & Lessons

New Paradigms in Alzheimer’s Disease Drug Development - Eric Siemers

SENS Research Foundation

Cynthia Carlsson, MD, discusses a groundbreaking phase 3 Alzheimer’s clinical trial at UW

UW School of Medicine and Public Health

Tau Immunotherapy and Imaging - Einar Sigurdsson

SENS Research Foundation

What’s New in Alzheimer’s Disease Clinical Trials?

Michigan Medicine

Alzheimer's Clinical Trial

Combatting Alzheimer's

School of Medicine, Medical Sciences and Nutrition

TauRx - The Importance of Ongoing Research in Alzheimer’s Disease

Alzheimer's clinical trial drug yields negative result

Tau Protein Pathology in Alzheimer's Disease

TauRxTherapeutics

Clinical trial hailed as "game changer" for Alzheimer's

CBS Evening News